Haemophilia Trial, Recruiting NCT07682519 Sponsor: University of Chile Condition: Haemophilia
Back to Haemophilia

Haemophilia Trial, Recruiting

NCT07682519
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men between the ages of 18 and 60 years old
  • People who have been diagnosed with hemophilia A or hemophilia B
  • People who experience ongoing pain that occurs every day, or on at least half of all days, over the past 3 to 6 months
  • People whose pain involves the elbow, knee, or ankle
  • People who are currently receiving clotting factor replacement treatment at least three times per week as a preventive measure
  • People who currently have a referral from a doctor to attend physical therapy
  • People who live in the Metropolitan Region of Chile
  • People who are able to understand what the study involves and are willing to sign a consent form

Who may not be able to join:

  • People who are unable to understand the study instructions or are unable to provide written consent
  • People who have a neurological condition affecting the brain or spinal cord, such as a stroke
  • People who are currently using other therapies specifically to manage their pain
  • People who have previously taken part in a pain neuroscience education program
  • People who have had orthopedic surgery or a significant injury to muscles, bones, or joints within the past 12 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +56928777254

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Chile
Registry
ClinicalTrials.gov
Start date
2 July 2026
Est. completion
15 January 2027

Where this trial is recruiting

🇨🇱 Chile

Primary endpoints

Pain Intensity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov